|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.71 USD | +1.82% |
|
+3.13% | +12.72% |
Executive Committee: Kymera Therapeutics, Inc.
| Manager | Positions heldSince | ||||||
|---|---|---|---|---|---|---|---|
Nello Mainolfi 47 year |
| ||||||
Vijay Sabesan 53 year |
| ||||||
Justine E. Koenigsberg |
| ||||||
Jeremy Chadwick 63 year |
| ||||||
Aimee Mishkin |
| ||||||
Karen Weisbach |
| ||||||
Jared Gollob 62 year |
| ||||||
Bruce Jacobs 56 year |
| ||||||
Brian Adams 52 year |
|
Composition of the Board of Directors: Kymera Therapeutics, Inc.
| Director | CommitteesSince | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Bruce Booth 51 year |
| ||||||||
John Maraganore 62 year |
| ||||||||
Felix Baker 57 year |
| ||||||||
Gorjan Hrustanovic 37 year |
| ||||||||
Jeffrey Albers 54 year |
| ||||||||
Pamela Esposito 52 year |
| ||||||||
Victor Sandor 59 year |
| ||||||||
Elena Ridloff 46 year |
| ||||||||
Nello Mainolfi 47 year |
|
Latest Appointments: Kymera Therapeutics, Inc.
Former Officers and Directors: Kymera Therapeutics, Inc.
| Insider | Positions held SinceUntil | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
|
Age distribution of managers
Parity Men Women
| Male | 16 |
|---|---|
| Female | 4 |
Of which Executive Committee
| Male | 6 |
|---|---|
| Female | 3 |
Of which Directors
| Male | 8 |
|---|---|
| Female | 1 |
Revisions
ESG MSCI
Departures of Key Persons
Chief Executive Officer
- 31/05/2019
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















